Indian Accounting Research Analyst, Trudence Capital Advisors

Nitin Mangal

Nitin Mangal is a Research Analyst with more than 15 years of experience in Indian equities. He is Pioneer of Corporate Governance and Accounting Research in Indian Market and has successfully developed product for Institutional Investors named as "Analysis Beyond Consensus" during his association with Edelweiss Securities Ltd, Mumbai. Later during the career, he has worked with Veritas Investment Research Corporation, Canada as Asia Consultant covering Indian and US equities. He has been profiled by leading financial newspapers such as Wall Street Journal, Business Standard etc

Indian Accounting Research Analyst

COVID-19 : Intermediate Respite for Some Businesses

Lockdown 3.0: Red Zones Opening A Gamble?

Covid-19 Action Plan: Too Little Too Late

India Economic Package: Baby Steps In Right Direction But The Fish Is Big

Thematic (Sector/Industry)

India Health care / Thematic (Sector/Industry)

<p>COVID-19 pandemic has dug its roots in India and the situation has warmed up good. The country is still in the early-mid phase of the exponential path which the virus beholds, hence the toxicity is likely to aggravate. The honorable P.M declared the 21-day lockdown two weeks ago to battle the pandemic, however, what's important is how far the purpose of lockdown was achieved regarding the testing and infections and what is there in store for the immediate future.</p>

COVID-19 pandemic has dug its roots in India and the situation has warmed up good. The country is still in the early-mid phase of the exponential path which the virus beholds, hence the toxicity is likely to aggravate. The honorable P.M declared the 21-day lockdown two weeks ago to battle the pandemic, however, what's important is how far the purpose of lockdown was achieved regarding the testing and infections and what is there in store for the immediate future.

Metropolis Healthcare Limited (METROHL IN)

COVID-19: How Does India Fare Currently?